Global Influenza Vaccine Market Insights, Forecast to 2029

Global Influenza Vaccine Market Insights, Forecast to 2029

Table of Contents
1 Study Coverage
1.1 Influenza Vaccine Product Introduction
1.2 Market by Type
1.2.1 Global Influenza Vaccine Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Trivalent Influenza Vaccine
1.2.3 Quadrivalent Influenza Vaccine
1.3 Market by Application
1.3.1 Global Influenza Vaccine Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 6 Months to 3 Years
1.3.3 > 3 Years
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Influenza Vaccine Sales Estimates and Forecasts 2018-2029
2.2 Global Influenza Vaccine Revenue by Region
2.2.1 Global Influenza Vaccine Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Influenza Vaccine Revenue by Region (2018-2023)
2.2.3 Global Influenza Vaccine Revenue by Region (2024-2029)
2.2.4 Global Influenza Vaccine Revenue Market Share by Region (2018-2029)
2.3 Global Influenza Vaccine Sales Estimates and Forecasts 2018-2029
2.4 Global Influenza Vaccine Sales by Region
2.4.1 Global Influenza Vaccine Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Influenza Vaccine Sales by Region (2018-2023)
2.4.3 Global Influenza Vaccine Sales by Region (2024-2029)
2.4.4 Global Influenza Vaccine Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Influenza Vaccine Sales by Manufacturers
3.1.1 Global Influenza Vaccine Sales by Manufacturers (2018-2023)
3.1.2 Global Influenza Vaccine Sales Market Share by Manufacturers (2018-2023)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Influenza Vaccine in 2022
3.2 Global Influenza Vaccine Revenue by Manufacturers
3.2.1 Global Influenza Vaccine Revenue by Manufacturers (2018-2023)
3.2.2 Global Influenza Vaccine Revenue Market Share by Manufacturers (2018-2023)
3.2.3 Global Top 10 and Top 5 Companies by Influenza Vaccine Revenue in 2022
3.3 Global Key Players of Influenza Vaccine, Industry Ranking, 2021 VS 2022 VS 2023
3.4 Global Influenza Vaccine Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Influenza Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Influenza Vaccine, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Influenza Vaccine, Product Offered and Application
3.8 Global Key Manufacturers of Influenza Vaccine, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Influenza Vaccine Sales by Type
4.1.1 Global Influenza Vaccine Historical Sales by Type (2018-2023)
4.1.2 Global Influenza Vaccine Forecasted Sales by Type (2024-2029)
4.1.3 Global Influenza Vaccine Sales Market Share by Type (2018-2029)
4.2 Global Influenza Vaccine Revenue by Type
4.2.1 Global Influenza Vaccine Historical Revenue by Type (2018-2023)
4.2.2 Global Influenza Vaccine Forecasted Revenue by Type (2024-2029)
4.2.3 Global Influenza Vaccine Revenue Market Share by Type (2018-2029)
4.3 Global Influenza Vaccine Price by Type
4.3.1 Global Influenza Vaccine Price by Type (2018-2023)
4.3.2 Global Influenza Vaccine Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Influenza Vaccine Sales by Application
5.1.1 Global Influenza Vaccine Historical Sales by Application (2018-2023)
5.1.2 Global Influenza Vaccine Forecasted Sales by Application (2024-2029)
5.1.3 Global Influenza Vaccine Sales Market Share by Application (2018-2029)
5.2 Global Influenza Vaccine Revenue by Application
5.2.1 Global Influenza Vaccine Historical Revenue by Application (2018-2023)
5.2.2 Global Influenza Vaccine Forecasted Revenue by Application (2024-2029)
5.2.3 Global Influenza Vaccine Revenue Market Share by Application (2018-2029)
5.3 Global Influenza Vaccine Price by Application
5.3.1 Global Influenza Vaccine Price by Application (2018-2023)
5.3.2 Global Influenza Vaccine Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Influenza Vaccine Market Size by Type
6.1.1 US & Canada Influenza Vaccine Sales by Type (2018-2029)
6.1.2 US & Canada Influenza Vaccine Revenue by Type (2018-2029)
6.2 US & Canada Influenza Vaccine Market Size by Application
6.2.1 US & Canada Influenza Vaccine Sales by Application (2018-2029)
6.2.2 US & Canada Influenza Vaccine Revenue by Application (2018-2029)
6.3 US & Canada Influenza Vaccine Market Size by Country
6.3.1 US & Canada Influenza Vaccine Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Influenza Vaccine Sales by Country (2018-2029)
6.3.3 US & Canada Influenza Vaccine Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Influenza Vaccine Market Size by Type
7.1.1 Europe Influenza Vaccine Sales by Type (2018-2029)
7.1.2 Europe Influenza Vaccine Revenue by Type (2018-2029)
7.2 Europe Influenza Vaccine Market Size by Application
7.2.1 Europe Influenza Vaccine Sales by Application (2018-2029)
7.2.2 Europe Influenza Vaccine Revenue by Application (2018-2029)
7.3 Europe Influenza Vaccine Market Size by Country
7.3.1 Europe Influenza Vaccine Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Influenza Vaccine Sales by Country (2018-2029)
7.3.3 Europe Influenza Vaccine Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Influenza Vaccine Market Size
8.1.1 China Influenza Vaccine Sales (2018-2029)
8.1.2 China Influenza Vaccine Revenue (2018-2029)
8.2 China Influenza Vaccine Market Size by Application
8.2.1 China Influenza Vaccine Sales by Application (2018-2029)
8.2.2 China Influenza Vaccine Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Influenza Vaccine Market Size by Type
9.1.1 Asia Influenza Vaccine Sales by Type (2018-2029)
9.1.2 Asia Influenza Vaccine Revenue by Type (2018-2029)
9.2 Asia Influenza Vaccine Market Size by Application
9.2.1 Asia Influenza Vaccine Sales by Application (2018-2029)
9.2.2 Asia Influenza Vaccine Revenue by Application (2018-2029)
9.3 Asia Influenza Vaccine Sales by Region
9.3.1 Asia Influenza Vaccine Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Influenza Vaccine Revenue by Region (2018-2029)
9.3.3 Asia Influenza Vaccine Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Influenza Vaccine Market Size by Type
10.1.1 Middle East, Africa and Latin America Influenza Vaccine Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Influenza Vaccine Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Influenza Vaccine Market Size by Application
10.2.1 Middle East, Africa and Latin America Influenza Vaccine Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Influenza Vaccine Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Influenza Vaccine Sales by Country
10.3.1 Middle East, Africa and Latin America Influenza Vaccine Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Influenza Vaccine Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Influenza Vaccine Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Sanofi
11.1.1 Sanofi Company Information
11.1.2 Sanofi Overview
11.1.3 Sanofi Influenza Vaccine Sales, Price, Revenue and Gross Margin (2018-2023)
11.1.4 Sanofi Influenza Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Sanofi Recent Developments
11.2 CSL
11.2.1 CSL Company Information
11.2.2 CSL Overview
11.2.3 CSL Influenza Vaccine Sales, Price, Revenue and Gross Margin (2018-2023)
11.2.4 CSL Influenza Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 CSL Recent Developments
11.3 GSK
11.3.1 GSK Company Information
11.3.2 GSK Overview
11.3.3 GSK Influenza Vaccine Sales, Price, Revenue and Gross Margin (2018-2023)
11.3.4 GSK Influenza Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 GSK Recent Developments
11.4 Viatris
11.4.1 Viatris Company Information
11.4.2 Viatris Overview
11.4.3 Viatris Influenza Vaccine Sales, Price, Revenue and Gross Margin (2018-2023)
11.4.4 Viatris Influenza Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Viatris Recent Developments
11.5 AstraZeneca
11.5.1 AstraZeneca Company Information
11.5.2 AstraZeneca Overview
11.5.3 AstraZeneca Influenza Vaccine Sales, Price, Revenue and Gross Margin (2018-2023)
11.5.4 AstraZeneca Influenza Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 AstraZeneca Recent Developments
11.6 Hualan Bio
11.6.1 Hualan Bio Company Information
11.6.2 Hualan Bio Overview
11.6.3 Hualan Bio Influenza Vaccine Sales, Price, Revenue and Gross Margin (2018-2023)
11.6.4 Hualan Bio Influenza Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Hualan Bio Recent Developments
11.7 Changchun Institute of Biological
11.7.1 Changchun Institute of Biological Company Information
11.7.2 Changchun Institute of Biological Overview
11.7.3 Changchun Institute of Biological Influenza Vaccine Sales, Price, Revenue and Gross Margin (2018-2023)
11.7.4 Changchun Institute of Biological Influenza Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Changchun Institute of Biological Recent Developments
11.8 Sinovac
11.8.1 Sinovac Company Information
11.8.2 Sinovac Overview
11.8.3 Sinovac Influenza Vaccine Sales, Price, Revenue and Gross Margin (2018-2023)
11.8.4 Sinovac Influenza Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Sinovac Recent Developments
11.9 BCHT
11.9.1 BCHT Company Information
11.9.2 BCHT Overview
11.9.3 BCHT Influenza Vaccine Sales, Price, Revenue and Gross Margin (2018-2023)
11.9.4 BCHT Influenza Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 BCHT Recent Developments
11.10 Jiangsu GDK
11.10.1 Jiangsu GDK Company Information
11.10.2 Jiangsu GDK Overview
11.10.3 Jiangsu GDK Influenza Vaccine Sales, Price, Revenue and Gross Margin (2018-2023)
11.10.4 Jiangsu GDK Influenza Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Jiangsu GDK Recent Developments
11.11 KM Biologics
11.11.1 KM Biologics Company Information
11.11.2 KM Biologics Overview
11.11.3 KM Biologics Influenza Vaccine Sales, Price, Revenue and Gross Margin (2018-2023)
11.11.4 KM Biologics Influenza Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 KM Biologics Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Influenza Vaccine Industry Chain Analysis
12.2 Influenza Vaccine Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Influenza Vaccine Production Mode & Process
12.4 Influenza Vaccine Sales and Marketing
12.4.1 Influenza Vaccine Sales Channels
12.4.2 Influenza Vaccine Distributors
12.5 Influenza Vaccine Customers
13 Market Dynamics
13.1 Influenza Vaccine Industry Trends
13.2 Influenza Vaccine Market Drivers
13.3 Influenza Vaccine Market Challenges
13.4 Influenza Vaccine Market Restraints
14 Key Findings in The Global Influenza Vaccine Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Influenza Vaccine Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Trivalent Influenza Vaccine
Table 3. Major Manufacturers of Quadrivalent Influenza Vaccine
Table 4. Global Influenza Vaccine Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 5. Global Influenza Vaccine Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Influenza Vaccine Revenue by Region (2018-2023) & (US$ Million)
Table 7. Global Influenza Vaccine Revenue by Region (2024-2029) & (US$ Million)
Table 8. Global Influenza Vaccine Revenue Market Share by Region (2018-2023)
Table 9. Global Influenza Vaccine Revenue Market Share by Region (2024-2029)
Table 10. Global Influenza Vaccine Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 11. Global Influenza Vaccine Sales by Region (2018-2023) & (M Doses)
Table 12. Global Influenza Vaccine Sales by Region (2024-2029) & (M Doses)
Table 13. Global Influenza Vaccine Sales Market Share by Region (2018-2023)
Table 14. Global Influenza Vaccine Sales Market Share by Region (2024-2029)
Table 15. Global Influenza Vaccine Sales by Manufacturers (2018-2023) & (M Doses)
Table 16. Global Influenza Vaccine Sales Share by Manufacturers (2018-2023)
Table 17. Global Influenza Vaccine Revenue by Manufacturers (2018-2023) & (US$ Million)
Table 18. Global Influenza Vaccine Revenue Share by Manufacturers (2018-2023)
Table 19. Global Key Players of Influenza Vaccine, Industry Ranking, 2021 VS 2022 VS 2023
Table 20. Influenza Vaccine Price by Manufacturers 2018-2023 (USD/Doses)
Table 21. Global Influenza Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Influenza Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Influenza Vaccine as of 2022)
Table 23. Global Key Manufacturers of Influenza Vaccine, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Influenza Vaccine, Product Offered and Application
Table 25. Global Key Manufacturers of Influenza Vaccine, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Influenza Vaccine Sales by Type (2018-2023) & (M Doses)
Table 28. Global Influenza Vaccine Sales by Type (2024-2029) & (M Doses)
Table 29. Global Influenza Vaccine Sales Share by Type (2018-2023)
Table 30. Global Influenza Vaccine Sales Share by Type (2024-2029)
Table 31. Global Influenza Vaccine Revenue by Type (2018-2023) & (US$ Million)
Table 32. Global Influenza Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 33. Global Influenza Vaccine Revenue Share by Type (2018-2023)
Table 34. Global Influenza Vaccine Revenue Share by Type (2024-2029)
Table 35. Influenza Vaccine Price by Type (2018-2023) & (USD/Doses)
Table 36. Global Influenza Vaccine Price Forecast by Type (2024-2029) & (USD/Doses)
Table 37. Global Influenza Vaccine Sales by Application (2018-2023) & (M Doses)
Table 38. Global Influenza Vaccine Sales by Application (2024-2029) & (M Doses)
Table 39. Global Influenza Vaccine Sales Share by Application (2018-2023)
Table 40. Global Influenza Vaccine Sales Share by Application (2024-2029)
Table 41. Global Influenza Vaccine Revenue by Application (2018-2023) & (US$ Million)
Table 42. Global Influenza Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 43. Global Influenza Vaccine Revenue Share by Application (2018-2023)
Table 44. Global Influenza Vaccine Revenue Share by Application (2024-2029)
Table 45. Influenza Vaccine Price by Application (2018-2023) & (USD/Doses)
Table 46. Global Influenza Vaccine Price Forecast by Application (2024-2029) & (USD/Doses)
Table 47. US & Canada Influenza Vaccine Sales by Type (2018-2023) & (M Doses)
Table 48. US & Canada Influenza Vaccine Sales by Type (2024-2029) & (M Doses)
Table 49. US & Canada Influenza Vaccine Revenue by Type (2018-2023) & (US$ Million)
Table 50. US & Canada Influenza Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 51. US & Canada Influenza Vaccine Sales by Application (2018-2023) & (M Doses)
Table 52. US & Canada Influenza Vaccine Sales by Application (2024-2029) & (M Doses)
Table 53. US & Canada Influenza Vaccine Revenue by Application (2018-2023) & (US$ Million)
Table 54. US & Canada Influenza Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 55. US & Canada Influenza Vaccine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 56. US & Canada Influenza Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 57. US & Canada Influenza Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 58. US & Canada Influenza Vaccine Sales by Country (2018-2023) & (M Doses)
Table 59. US & Canada Influenza Vaccine Sales by Country (2024-2029) & (M Doses)
Table 60. Europe Influenza Vaccine Sales by Type (2018-2023) & (M Doses)
Table 61. Europe Influenza Vaccine Sales by Type (2024-2029) & (M Doses)
Table 62. Europe Influenza Vaccine Revenue by Type (2018-2023) & (US$ Million)
Table 63. Europe Influenza Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 64. Europe Influenza Vaccine Sales by Application (2018-2023) & (M Doses)
Table 65. Europe Influenza Vaccine Sales by Application (2024-2029) & (M Doses)
Table 66. Europe Influenza Vaccine Revenue by Application (2018-2023) & (US$ Million)
Table 67. Europe Influenza Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 68. Europe Influenza Vaccine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 69. Europe Influenza Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 70. Europe Influenza Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 71. Europe Influenza Vaccine Sales by Country (2018-2023) & (M Doses)
Table 72. Europe Influenza Vaccine Sales by Country (2024-2029) & (M Doses)
Table 73. China Influenza Vaccine Sales by Type (2018-2023) & (M Doses)
Table 74. China Influenza Vaccine Sales by Type (2024-2029) & (M Doses)
Table 75. China Influenza Vaccine Revenue by Type (2018-2023) & (US$ Million)
Table 76. China Influenza Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 77. China Influenza Vaccine Sales by Application (2018-2023) & (M Doses)
Table 78. China Influenza Vaccine Sales by Application (2024-2029) & (M Doses)
Table 79. China Influenza Vaccine Revenue by Application (2018-2023) & (US$ Million)
Table 80. China Influenza Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 81. Asia Influenza Vaccine Sales by Type (2018-2023) & (M Doses)
Table 82. Asia Influenza Vaccine Sales by Type (2024-2029) & (M Doses)
Table 83. Asia Influenza Vaccine Revenue by Type (2018-2023) & (US$ Million)
Table 84. Asia Influenza Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 85. Asia Influenza Vaccine Sales by Application (2018-2023) & (M Doses)
Table 86. Asia Influenza Vaccine Sales by Application (2024-2029) & (M Doses)
Table 87. Asia Influenza Vaccine Revenue by Application (2018-2023) & (US$ Million)
Table 88. Asia Influenza Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 89. Asia Influenza Vaccine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 90. Asia Influenza Vaccine Revenue by Region (2018-2023) & (US$ Million)
Table 91. Asia Influenza Vaccine Revenue by Region (2024-2029) & (US$ Million)
Table 92. Asia Influenza Vaccine Sales by Region (2018-2023) & (M Doses)
Table 93. Asia Influenza Vaccine Sales by Region (2024-2029) & (M Doses)
Table 94. Middle East, Africa and Latin America Influenza Vaccine Sales by Type (2018-2023) & (M Doses)
Table 95. Middle East, Africa and Latin America Influenza Vaccine Sales by Type (2024-2029) & (M Doses)
Table 96. Middle East, Africa and Latin America Influenza Vaccine Revenue by Type (2018-2023) & (US$ Million)
Table 97. Middle East, Africa and Latin America Influenza Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 98. Middle East, Africa and Latin America Influenza Vaccine Sales by Application (2018-2023) & (M Doses)
Table 99. Middle East, Africa and Latin America Influenza Vaccine Sales by Application (2024-2029) & (M Doses)
Table 100. Middle East, Africa and Latin America Influenza Vaccine Revenue by Application (2018-2023) & (US$ Million)
Table 101. Middle East, Africa and Latin America Influenza Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 102. Middle East, Africa and Latin America Influenza Vaccine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 103. Middle East, Africa and Latin America Influenza Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 104. Middle East, Africa and Latin America Influenza Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 105. Middle East, Africa and Latin America Influenza Vaccine Sales by Country (2018-2023) & (M Doses)
Table 106. Middle East, Africa and Latin America Influenza Vaccine Sales by Country (2024-2029) & (M Doses)
Table 107. Sanofi Company Information
Table 108. Sanofi Description and Major Businesses
Table 109. Sanofi Influenza Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2018-2023)
Table 110. Sanofi Influenza Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Sanofi Recent Developments
Table 112. CSL Company Information
Table 113. CSL Description and Major Businesses
Table 114. CSL Influenza Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2018-2023)
Table 115. CSL Influenza Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. CSL Recent Developments
Table 117. GSK Company Information
Table 118. GSK Description and Major Businesses
Table 119. GSK Influenza Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2018-2023)
Table 120. GSK Influenza Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. GSK Recent Developments
Table 122. Viatris Company Information
Table 123. Viatris Description and Major Businesses
Table 124. Viatris Influenza Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2018-2023)
Table 125. Viatris Influenza Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Viatris Recent Developments
Table 127. AstraZeneca Company Information
Table 128. AstraZeneca Description and Major Businesses
Table 129. AstraZeneca Influenza Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2018-2023)
Table 130. AstraZeneca Influenza Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. AstraZeneca Recent Developments
Table 132. Hualan Bio Company Information
Table 133. Hualan Bio Description and Major Businesses
Table 134. Hualan Bio Influenza Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2018-2023)
Table 135. Hualan Bio Influenza Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Hualan Bio Recent Developments
Table 137. Changchun Institute of Biological Company Information
Table 138. Changchun Institute of Biological Description and Major Businesses
Table 139. Changchun Institute of Biological Influenza Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2018-2023)
Table 140. Changchun Institute of Biological Influenza Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. Changchun Institute of Biological Recent Developments
Table 142. Sinovac Company Information
Table 143. Sinovac Description and Major Businesses
Table 144. Sinovac Influenza Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2018-2023)
Table 145. Sinovac Influenza Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. Sinovac Recent Developments
Table 147. BCHT Company Information
Table 148. BCHT Description and Major Businesses
Table 149. BCHT Influenza Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2018-2023)
Table 150. BCHT Influenza Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. BCHT Recent Developments
Table 152. Jiangsu GDK Company Information
Table 153. Jiangsu GDK Description and Major Businesses
Table 154. Jiangsu GDK Influenza Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2018-2023)
Table 155. Jiangsu GDK Influenza Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 156. Jiangsu GDK Recent Developments
Table 157. KM Biologics Company Information
Table 158. KM Biologics Description and Major Businesses
Table 159. KM Biologics Influenza Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2018-2023)
Table 160. KM Biologics Influenza Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 161. KM Biologics Recent Developments
Table 162. Key Raw Materials Lists
Table 163. Raw Materials Key Suppliers Lists
Table 164. Influenza Vaccine Distributors List
Table 165. Influenza Vaccine Customers List
Table 166. Influenza Vaccine Market Trends
Table 167. Influenza Vaccine Market Drivers
Table 168. Influenza Vaccine Market Challenges
Table 169. Influenza Vaccine Market Restraints
Table 170. Research Programs/Design for This Report
Table 171. Key Data Information from Secondary Sources
Table 172. Key Data Information from Primary Sources
List of Figures
Figure 1. Influenza Vaccine Product Picture
Figure 2. Global Influenza Vaccine Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Influenza Vaccine Market Share by Type in 2022 & 2029
Figure 4. Trivalent Influenza Vaccine Product Picture
Figure 5. Quadrivalent Influenza Vaccine Product Picture
Figure 6. Global Influenza Vaccine Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 7. Global Influenza Vaccine Market Share by Application in 2022 & 2029
Figure 8. 6 Months to 3 Years
Figure 9. > 3 Years
Figure 10. Influenza Vaccine Report Years Considered
Figure 11. Global Influenza Vaccine Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global Influenza Vaccine Revenue 2018-2029 (US$ Million)
Figure 13. Global Influenza Vaccine Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 14. Global Influenza Vaccine Revenue Market Share by Region (2018-2029)
Figure 15. Global Influenza Vaccine Sales 2018-2029 ((M Doses)
Figure 16. Global Influenza Vaccine Sales Market Share by Region (2018-2029)
Figure 17. US & Canada Influenza Vaccine Sales YoY (2018-2029) & (M Doses)
Figure 18. US & Canada Influenza Vaccine Revenue YoY (2018-2029) & (US$ Million)
Figure 19. Europe Influenza Vaccine Sales YoY (2018-2029) & (M Doses)
Figure 20. Europe Influenza Vaccine Revenue YoY (2018-2029) & (US$ Million)
Figure 21. China Influenza Vaccine Sales YoY (2018-2029) & (M Doses)
Figure 22. China Influenza Vaccine Revenue YoY (2018-2029) & (US$ Million)
Figure 23. Asia (excluding China) Influenza Vaccine Sales YoY (2018-2029) & (M Doses)
Figure 24. Asia (excluding China) Influenza Vaccine Revenue YoY (2018-2029) & (US$ Million)
Figure 25. Middle East, Africa and Latin America Influenza Vaccine Sales YoY (2018-2029) & (M Doses)
Figure 26. Middle East, Africa and Latin America Influenza Vaccine Revenue YoY (2018-2029) & (US$ Million)
Figure 27. The Influenza Vaccine Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 28. The Top 5 and 10 Largest Manufacturers of Influenza Vaccine in the World: Market Share by Influenza Vaccine Revenue in 2022
Figure 29. Global Influenza Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 30. Global Influenza Vaccine Sales Market Share by Type (2018-2029)
Figure 31. Global Influenza Vaccine Revenue Market Share by Type (2018-2029)
Figure 32. Global Influenza Vaccine Sales Market Share by Application (2018-2029)
Figure 33. Global Influenza Vaccine Revenue Market Share by Application (2018-2029)
Figure 34. US & Canada Influenza Vaccine Sales Market Share by Type (2018-2029)
Figure 35. US & Canada Influenza Vaccine Revenue Market Share by Type (2018-2029)
Figure 36. US & Canada Influenza Vaccine Sales Market Share by Application (2018-2029)
Figure 37. US & Canada Influenza Vaccine Revenue Market Share by Application (2018-2029)
Figure 38. US & Canada Influenza Vaccine Revenue Share by Country (2018-2029)
Figure 39. US & Canada Influenza Vaccine Sales Share by Country (2018-2029)
Figure 40. U.S. Influenza Vaccine Revenue (2018-2029) & (US$ Million)
Figure 41. Canada Influenza Vaccine Revenue (2018-2029) & (US$ Million)
Figure 42. Europe Influenza Vaccine Sales Market Share by Type (2018-2029)
Figure 43. Europe Influenza Vaccine Revenue Market Share by Type (2018-2029)
Figure 44. Europe Influenza Vaccine Sales Market Share by Application (2018-2029)
Figure 45. Europe Influenza Vaccine Revenue Market Share by Application (2018-2029)
Figure 46. Europe Influenza Vaccine Revenue Share by Country (2018-2029)
Figure 47. Europe Influenza Vaccine Sales Share by Country (2018-2029)
Figure 48. Germany Influenza Vaccine Revenue (2018-2029) & (US$ Million)
Figure 49. France Influenza Vaccine Revenue (2018-2029) & (US$ Million)
Figure 50. U.K. Influenza Vaccine Revenue (2018-2029) & (US$ Million)
Figure 51. Italy Influenza Vaccine Revenue (2018-2029) & (US$ Million)
Figure 52. Russia Influenza Vaccine Revenue (2018-2029) & (US$ Million)
Figure 53. China Influenza Vaccine Sales Market Share by Type (2018-2029)
Figure 54. China Influenza Vaccine Revenue Market Share by Type (2018-2029)
Figure 55. China Influenza Vaccine Sales Market Share by Application (2018-2029)
Figure 56. China Influenza Vaccine Revenue Market Share by Application (2018-2029)
Figure 57. Asia Influenza Vaccine Sales Market Share by Type (2018-2029)
Figure 58. Asia Influenza Vaccine Revenue Market Share by Type (2018-2029)
Figure 59. Asia Influenza Vaccine Sales Market Share by Application (2018-2029)
Figure 60. Asia Influenza Vaccine Revenue Market Share by Application (201

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Encephalitis Vaccination Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 102

According to our LPI (LP Information) latest study, the global Encephalitis Vaccination market size was valued at US$ 1263.1 million in 2023. With growing demand in downstream market, the Encephalitis Vaccination is forecast to a readjusted size of US$ 1875.5 million by 2030 with a CAGR of 5.8% during review period. The research report highlights the growth potential of the global Encephalitis Vaccination market. Encephalitis Vaccination are expected to show stable growth in the future m......

Global Avian Influenza Vaccines Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 123

Market Overview of Global Avian Influenza Vaccines market: According to our latest research, the global Avian Influenza Vaccines market looks promising in the next 5 years. As of 2022, the global Avian Influenza Vaccines market was estimated at USD 933.69 million, and it's anticipated to reach USD 1586.45 million in 2028, with a CAGR of 9.24% during the forecast years. Avian influenza refers to the disease caused by infection with avian (bird) influenza (flu) Type A viruses. ......

Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 96

According to our LPI (LP Information) latest study, the global 23-Valent Pneumococcal Polysaccharide Vaccine market size was valued at US$ 1114.7 million in 2023. With growing demand in downstream market, the 23-Valent Pneumococcal Polysaccharide Vaccine is forecast to a readjusted size of US$ 2265.8 million by 2030 with a CAGR of 10.7% during review period. The research report highlights the growth potential of the global 23-Valent Pneumococcal Polysaccharide Vaccine market. 23-Valent P......

Global Avian Influenza Vaccines Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 155

According to our LPI (LP Information) latest study, the global Avian Influenza Vaccines market size was valued at US$ 928.4 million in 2023. With growing demand in downstream market, the Avian Influenza Vaccines is forecast to a readjusted size of US$ 1369 million by 2030 with a CAGR of 5.7% during review period. The research report highlights the growth potential of the global Avian Influenza Vaccines market. Avian Influenza Vaccines are expected to show stable growth in the future mark......

Global Encephalitis Vaccination Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 28-Dec-2023        Price: US 3380 Onwards        Pages: 106

Market Overview of Global Encephalitis Vaccination market: According to our latest research, the global Encephalitis Vaccination market looks promising in the next 5 years. As of 2022, the global Encephalitis Vaccination market was estimated at USD 52963.61 million, and it's anticipated to reach USD 65320.29 million in 2028, with a CAGR of 3.56% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis......

Global Influenza Vaccine Market Research Report 2023

Published: 28-Dec-2023        Price: US 2900 Onwards        Pages: 96

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Influenza Vaccine market with multiple angles, which provides sufficient supports to readers' strategy and decision making. By Company - Sanofi - CSL - GSK - Viatris - AstraZeneca - Hualan Bio - Changchun Institute of Biological - Sinovac - BCHT - Jiangsu G......

Global Japanese Encephalitis Vaccine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 26-Dec-2023        Price: US 3380 Onwards        Pages: 117

Market Overview of Global Japanese Encephalitis Vaccine market: According to our latest research, the global Japanese Encephalitis Vaccine market looks promising in the next 5 years. As of 2022, the global Japanese Encephalitis Vaccine market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysi......

Global Influenza Vaccine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 14-Dec-2023        Price: US 3380 Onwards        Pages: 103

Market Overview of Global Influenza Vaccine market: According to our latest research, the global Influenza Vaccine market looks promising in the next 5 years. As of 2022, the global Influenza Vaccine market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. Influenza vaccines, also known as flu shots or flu jabs, are vaccines that protect against infection by influenza viruses... ......

2023-2031 Report on Global Influenza Vaccine Market by Player, Region, Type, Application and Sales Channel

Published: 11-Dec-2023        Price: US 2500 Onwards        Pages: 107

This report studies the Influenza Vaccine market, covering market size for segment by type (Inactivated Vaccine, Live Attenuated Vaccine, etc.), by application (Pediatric, Adults, etc.), by sales channel (Direct Channel, Distribution Channel), by player (CSL, GSK, Sanofi, Mylan, AstraZeneca, etc.) and by region (North America, Europe, Asia-Pacific, South America and Middle East & Africa). This report provides detailed historical analysis of global market for Influenza Vaccine from......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs